HJ-PI01

Names

[ Name ]:
HJ-PI01

[Synonym ]:
UNII-VVA9DLS3TV
10-Acetyl-phenoxazin
N-Acetylphenoxazine
Phenoxazine,10-acetyl
10-acetyl-phenoxazine
10-acetyl-10H-phenoxazine

Biological Activity

[Description]:

HJ-PI01 (10-Acetylphenoxazine) is an orally active Pim-2 inhibitor. HJ-PI01 induces apoptosis and autophagic cell death of cancer cells. HJ-PI01 inhibits tumor growth in MDA-MB-231 xenograft mice. HJ-PI01 can be used for cancer research[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> JAK/STAT Signaling >> Pim

[In Vitro]

HJ-PI01 (0-3200 nmol/L；48 小时) 剂量性依赖地抑制 MDA-MB-231 细胞生长，与氯丙嗪和 PI003 相比效果更为显著改善[1]。 HJ-PI01 (100-400 nmol/L；24 小时) 对正常非癌细胞显示弱毒性[1]。 HJ-PI01 (300 nmol/L；24 小时) 诱导 MDA-MB-231 细胞自噬性细胞死亡[1]。 HJ-PI01 (300 nmol/L；24 小时) 诱导 MDA-MB-231 细胞凋亡性死亡[1]。 HJ-PI01 (300 和 460 nmol/L；12-48 小时) 影响自噬和凋亡相关蛋白的表达水平[1]。 Western Blot Analysis[1] Cell Line: MDA-MB-231 cell line Concentration: 300 and 460 nmol/L Incubation Time: 12, 24, 36 and 48 hours Result: Time-dependently increased LC3-II and Beclin-1 and induced p62 degradation in MDA-MB-231 cells. Increased the level of Bax. Decreased the level of Bcl-2, and Pim-2 and Pim-2 phosphorylation. Activated caspase-9 and caspase-3.

[In Vivo]

HJ-PI01 (40 mg/kg；口服，每日 1 次，持续 10 天) 抑制 MDA-MB-231 异种移植小鼠肿瘤生长[1]。 Animal Model: BALB/c female nude mice with MDA-MB-231 cells injection[1] Dosage: 40 mg/kg Administration: Oral administration; 40 mg/kg, once daily for 10 days Result: Significantly inhibited tumor growth with an obvious decreasing of the body, liver, spleen and kidney weights of the mice.

[References]

[1]. Zhao YQ, et al. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer. Acta Pharmacol Sin. 2016 Sep;37(9):1237-50.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₄H₁₁NO₂

[ Molecular Weight ]:
225.24300

[ Exact Mass ]:
225.07900

[ PSA ]:
29.54000

[ LogP ]:
3.54190

Synthetic Route

Click to get detail synthetic route

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.